Loncastuximab (Anti-CD19)
Loncastuximab (Anti-CD19) is a monoclonal antibody targeting CD19. It shows antitumor activity and has potential application in non-Hodgkin's lymphoma (NHL), including diffuse large B-cell lymphoma (DLBCL). MW :144.38 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A3160 |
| Sku # | A3160-1mg*5 |
| Pricing | 1mg*5, $970.00 |